Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “de Novo Lesions in Native Coronary Arteries”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Post-approval studies (Phase 4)Study completedNCT00495898
What this trial is testing

Diabetic Patients With De Novo Native Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 200
Not applicableUnknownNCT02663323
What this trial is testing

Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System

Who this might be right for
Coronary Artery Disease
Meril Life Sciences Pvt. Ltd. 64
Large-scale testing (Phase 3)Study completedNCT00232791
What this trial is testing

The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions.

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 102
Large-scale testing (Phase 3)Study completedNCT00232752
What this trial is testing

Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 100
Not applicableLooking for participantsNCT07091682
What this trial is testing

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

Who this might be right for
Coronary Artery DiseaseAtherosclerosis of Coronary ArteryMyocardial Ischemia+3 more
Biotronik AG 100
Not applicableStudy completedNCT00811616
What this trial is testing

A Safety and Efficacy of Supralimus™ Core™ Sirolimus Eluting Stent at MAX DDHV Institute

Who this might be right for
Coronary Artery Disease
Sahajanand Medical Technologies Limited 105
Not applicableStudy completedNCT01168830
What this trial is testing

First in Man Trial - BIOSOLVE-I

Who this might be right for
de Novo Lesions in Native Coronary Arteries
Biotronik AG 46
Not applicableStudy completedNCT00314275
What this trial is testing

The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System

Who this might be right for
Coronary Artery Disease
Medtronic Vascular 43
Post-approval studies (Phase 4)Ended earlyNCT00917163
What this trial is testing

SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent

Who this might be right for
Coronary Artery Disease
Sahajanand Medical Technologies Limited 13
Not applicableStudy completedNCT02086006
What this trial is testing

Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 16
Not applicableStudy completedNCT02009956
What this trial is testing

EXCELLA Post-Approval Study

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 57
Large-scale testing (Phase 3)Study completedNCT00165035
What this trial is testing

Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)

Who this might be right for
Coronary Disease
Cordis US Corp. 1,701
Not applicableStudy completedNCT02542007
What this trial is testing

Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions

Who this might be right for
Coronary Arteriosclerosis
OrbusNeich 440
Not applicableActive Not RecruitingNCT04157153
What this trial is testing

First in Men Study: BIOMAG-I

Who this might be right for
Coronary Artery Disease
Biotronik AG 116
Not applicableEnded earlyNCT01025869
What this trial is testing

The Clinical Evaluation of the Cinatra™ Corolimus-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries

Who this might be right for
Coronary Artery Disease
Atrium Medical Corporation 31
Not applicableActive Not RecruitingNCT05540223
What this trial is testing

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System

Who this might be right for
Coronary Artery DiseaseAtherosclerosis, CoronaryMyocardial Ischemia+3 more
Biotronik AG 1,861
Not applicableStudy completedNCT00614848
What this trial is testing

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions

Who this might be right for
Coronary Artery DiseaseArterial Occlusive DiseasesCoronary Disease+6 more
Medtronic Vascular 1,200
Testing effectiveness (Phase 2)UnknownNCT00744107
What this trial is testing

Cobra II Study: Use of the Cobra™ Cobalt Super Alloy Coronary Stent System in the Treatment of Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Medlogics Device Corporation 258
Not applicableLooking for participantsNCT07038408
What this trial is testing

Leave Nothing Behind Study Which Compares DCB With Bail Out BRS Versus BRS Strategy Alone

Who this might be right for
Drug Coated BalloonBioresorbable ScaffoldPercutaneous Coronary Intervention (PCI)+1 more
Ceric Sàrl 2,256
Not applicableStudy completedNCT04034121
What this trial is testing

Elixir Medical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - Cx Registry

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 50
Next Page